Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Liabilities ₹12,449 Cr₹11,173 Cr₹10,611 Cr₹8,778 Cr₹7,834 Cr

What is the latest Total Liabilities ratio of GLAND PHARMA ?

The latest Total Liabilities ratio of GLAND PHARMA is ₹12,449 Cr based on Mar2026 Consolidated results.
Year Total Liabilities
Mar2026₹12,449 Cr
Mar2025₹11,173 Cr
Mar2024₹10,611 Cr
Mar2023₹8,778 Cr
Mar2022₹7,834 Cr

How is Total Liabilities of GLAND PHARMA Trending?

Years Total Liabilities % Change
Mar2026 ₹12,449 Cr
11.42
Mar2025 ₹11,173 Cr
5.30
Mar2024 ₹10,611 Cr
20.89
Mar2023 ₹8,778 Cr
12.05
Mar2022 ₹7,834 Cr -

Compare Total Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹49,071.8 Cr 3.7% 14.4% 57.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹455,826.0 Cr -1.6% -2.5% 21.4% Stock Analytics
DIVIS LABORATORIES ₹247,019.0 Cr 1.5% 12.8% 48.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,875.0 Cr -0.9% -0.8% 35.3% Stock Analytics
CIPLA ₹112,773.0 Cr -1.6% -5.2% -11.7% Stock Analytics
DR REDDYS LABORATORIES ₹95,570.9 Cr -2.2% -2.3% -8.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

3.7%

14.4%

57.3%

SENSEX

-1.1%

-3.6%

-5.3%


You may also like the below Video Courses